WallStSmart

Corteva Inc (CTVA)vsNutrien Ltd (NTR)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Nutrien Ltd generates 451% more annual revenue ($27.36B vs $4.97B). NTR leads profitability with a 8.0% profit margin vs 2.8%. CTVA appears more attractively valued with a PEG of 0.62. NTR earns a higher WallStSmart Score of 53/100 (C-).

CTVA

Buy

52

out of 100

Grade: C-

Growth: 2.0Profit: 5.0Value: 8.0Quality: 6.5
Piotroski: 5/9Altman Z: 1.49

NTR

Buy

53

out of 100

Grade: C-

Growth: 2.7Profit: 6.0Value: 4.7Quality: 5.8
Piotroski: 6/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTVAUndervalued (+3.4%)

Margin of Safety

+3.4%

Fair Value

$12.53

Current Price

$9.19

$3.34 discount

UndervaluedFair: $12.53Overvalued
NTRSignificantly Overvalued (-28.9%)

Margin of Safety

-28.9%

Fair Value

$56.69

Current Price

$71.22

$14.53 premium

UndervaluedFair: $56.69Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTVA4 strengths · Avg: 9.3/10
P/E RatioValuation
7.2x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.628/10

Growing faster than its price suggests

NTR2 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

Areas to Watch

CTVA4 concerns · Avg: 2.5/10
Return on EquityProfitability
4.0%3/10

ROE of 4.0% — below average capital efficiency

Profit MarginProfitability
2.8%3/10

2.8% margin — thin

Revenue GrowthGrowth
-1.2%2/10

Revenue declined 1.2%

EPS GrowthGrowth
-9.9%2/10

Earnings declined 9.9%

NTR4 concerns · Avg: 3.5/10
PEG RatioValuation
1.984/10

Expensive relative to growth rate

Revenue GrowthGrowth
1.2%4/10

1.2% revenue growth

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

EPS GrowthGrowth
-37.6%2/10

Earnings declined 37.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : CTVA

The strongest argument for CTVA centers on P/E Ratio, Price/Book, Debt/Equity. PEG of 0.62 suggests the stock is reasonably priced for its growth.

Bull Case : NTR

The strongest argument for NTR centers on Price/Book, P/E Ratio.

Bear Case : CTVA

The primary concerns for CTVA are Return on Equity, Profit Margin, Revenue Growth. Thin 2.8% margins leave little buffer for downturns.

Bear Case : NTR

The primary concerns for NTR are PEG Ratio, Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

NTR carries more volatility with a beta of 1.13 — expect wider price swings.

NTR is growing revenue faster at 1.2% — sustainability is the question.

CTVA generates stronger free cash flow (-588M), providing more financial flexibility.

Monitor AGRICULTURAL INPUTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NTR scores higher overall (53/100 vs 52/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Corteva Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Corteva, Inc. (also known as Corteva Agriscience) is a major American agricultural chemical and seed company that was the agricultural unit of DowDuPont prior to being spun off as an independent public company.

Visit Website →

Nutrien Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Nutrien Ltd. provides inputs, services and solutions for crops. The company is headquartered in Saskatoon, Canada.

Visit Website →

Want to dig deeper into these stocks?